01 — At a Glance
The Contract Manufacturer Nobody Knows But Defense Budgets Depend On
- 52-Week High / Low₹541 / ₹283
- Q3 FY26 Revenue₹303 Cr
- Q3 FY26 PAT₹11.2 Cr
- TTM EPS₹10.31
- Q3 EPS₹2.63
- Book Value / Share₹124
- Price to Book2.44x
- Order Book (Dec 2025)₹2,349 Cr
- Book-to-Bill Ratio1.3x
- Capacity Utilization50-60%
Flash Summary: Cyient DLM just reported Q3 revenue of ₹303 crore—down 31.7% YoY because a massive defense order completed in FY25. Sounds bad. It’s not. Q3 profit actually grew 2.18% YoY even as revenue crashed. Margins improved. Order book at ₹2,349 crore with 1.3x book-to-bill. They’re running at 50-60% capacity. P/E is 29.4x. And every major aerospace OEM on the planet has them on speed dial.
02 — Introduction
Making the Guts of Things That Fly (And Beep When You’re Sick)
Cyient DLM makes electronic components for aircraft, defense systems, medical devices, and industrial equipment. Their customer list reads like a greatest hits album of “companies you trust when your life depends on it”: Honeywell, Thales, ABB, Boeing, Bharat Electronics, Molbio Diagnostics. You’ve been flying in planes with their circuit boards for years. You’ve probably had their medical equipment scan you. You just didn’t know it.
They do circuit board assembly (70% of FY25 revenue), cable harnesses (2%), and box builds—which is a fancy way of saying “we’ll put your PCB inside a metal box and make sure it works.” Low-volume, high-mix manufacturing. Translation: customized, quality-critical, complex stuff. Every product needs validation. Every customer contract is 3–5 years long. It’s the opposite of “move fast and break things.”
Q3 FY26 looks like a disaster at first glance. Revenue crashed 31.7% YoY to ₹303 crore. But here’s the thing—it crashed because a large defense order finished executing in FY25. That order is done, delivered, certified. The company is now sitting on ₹2,349 crore of new orders waiting to ship, running at 50-60% capacity with room to double without new capex. In aerospace manufacturing logic, this is actually the setup for the next leg. Management said on the January 2026 concall: “the worst is behind us, at least from a revenue perspective.” If that’s true, and the order book ships on schedule, FY27 could be substantially better than FY26.
ICRA Rating Note (Mar 2026): ICRA AA- (Stable); cites “strong parentage with Cyient Limited holding ~52% stake,” “healthy business profile with reputed clientele,” and “order book of ~₹2,349 crore with book-to-bill ratio of ~1.5 times.” ICRA also notes “high working capital requirements” (NWC/OI at 18-38%) as a constraint. Stability outlook reflects “expected improvement in operating margins and scale over the medium term.”
03 — Business Model: Why Precision Beats Scale
Build One Thing Perfect. Then Wait 3 Years For It to Ship.
Members get full access to every article.
